Cargando…

Obesity in Older Type 2 Diabetic Patients: Does Working Environment Add Vulnerability?

Little is known about how working adults with type 2 diabetes are managing their health. This study aims to analyze the associations between health, behavioral, and sociodemographic characteristics and obesity in older diabetic patients in Europe. Data from the Survey of Health, Ageing, and Retireme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandão, Maria Piedade, Cardoso, Margarida Fonseca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313713/ https://www.ncbi.nlm.nih.gov/pubmed/30486498 http://dx.doi.org/10.3390/ijerph15122677

Ejemplares similares

Reliability and validity of the EASYCare-2010 Standard to assess elderly people in Portuguese Primary Health Care()
por: Brandão, Maria Piedade, et al.
Publicado: (2017)

Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
por: Neumiller, Joshua J.
Publicado: (2014)

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013)

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes
por: Iqbal, Nayyar, et al.
Publicado: (2014)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Trends in add-on medications following metformin monotherapy for type 2 diabetes
por: Swart, Elizabeth CS, et al.
Publicado: (2022)

Does undertaking rural placements add to place of origin as a predictor of where health graduates work?
por: Skinner, Timothy C., et al.
Publicado: (2022)

WORK ENVIRONMENTS AMONG OLDER WORKING CAREGIVERS
por: Carr, Dawn C, et al.
Publicado: (2019)

Diabetes and Obesity Associated with Poor Food Environments in American Indian Communities: the Tribal Health and Resilience in Vulnerable Environments (THRIVE) Study
por: Love, Charlotte V, et al.
Publicado: (2018)

Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study
por: Dailey, George E., et al.
Publicado: (2019)

Global Expression Profiling in Epileptogenesis: Does It Add to the Confusion?
por: Wang, Yi Yuen, et al.
Publicado: (2009)

Neck dissection does not add to morbidity or mortality of laryngectomy
por: Xiao, Christopher C., et al.
Publicado: (2019)

Bell’s palsy workup: Does audiometry add value?
por: Yuan, Jing, et al.
Publicado: (2021)

Intraoperative Rupture of Aneurysm: Does It Add Insult to the Injury?
por: Rao, Ganne Umamaheswara
Publicado: (2021)

3D Team Care Management Trial for Cognitively Vulnerable Older Adults: Who Participates and How Does the Team Work?
por: Fortinsky, Richard, et al.
Publicado: (2020)

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes
por: Ericsson, Åsa, et al.
Publicado: (2018)

Asthma and obesity: endotoxin another insult to add to injury?
por: Lad, Nikita, et al.
Publicado: (2021)

Exercise Training Adds Cardiometabolic Benefits of a Paleolithic Diet in Type 2 Diabetes Mellitus
por: Otten, Julia, et al.
Publicado: (2019)

Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
por: Odawara, Masato, et al.
Publicado: (2014)

Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?
por: Govaert, Klaas M., et al.
Publicado: (2012)

Valvular heart disease: what does cardiovascular MRI add?
por: Masci, Pier Giorgio, et al.
Publicado: (2007)

Does Pelvic Exam in the Emergency Department Add Useful Information?
por: Brown, Jeremy, et al.
Publicado: (2011)

Revitalizing Care Program in UK Healthcare: Does It Add Up?
por: Riley, Kay, et al.
Publicado: (2014)

The Global Health Security Index: what value does it add?
por: Razavi, Ahmed, et al.
Publicado: (2020)

What does ‘quality’ add? Towards an ethics of healthcare improvement
por: Cribb, Alan, et al.
Publicado: (2020)

Does sleep-disordered breathing add to impairments in academic performance and brain structure usually observed in children with overweight/obesity?
por: Torres-Lopez, Lucia V., et al.
Publicado: (2022)

Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes
por: Giampietro, Ottavio, et al.
Publicado: (2013)

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study
por: Tamez-Perez, Héctor Eloy, et al.
Publicado: (2017)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Enhanced vulnerability to distraction does not account for working memory capacity reduction in people with schizophrenia
por: Erickson, Molly, et al.
Publicado: (2014)

Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients
por: Huyen, V. T. T., et al.
Publicado: (2012)

Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
por: Li, Feng-fei, et al.
Publicado: (2017)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
por: Villar, Miriam Méndez-del, et al.
Publicado: (2017)

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
por: Rosenstock, Julio, et al.
Publicado: (2018)

Challenges of obesity and type 2 diabetes require more attention to food environment
por: Ladher, Navjoyt, et al.
Publicado: (2023)

Does Octreoscan add value in the differential diagnosis of parapharyngeal space lesions?
por: Dias, Raquel Baptista, et al.
Publicado: (2021)

Association of Vitamin D Levels with Type 2 Diabetes in Older Working Adults
por: Mauss, Daniel, et al.
Publicado: (2015)

A Genetic Link to Obesity: The Numbers Don't Add Up for GAD2
Publicado: (2005)

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
por: Li, Chun-jun, et al.
Publicado: (2012)

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
por: Fouqueray, Pascale, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jueqpgfp2g76hur7m7mj5238on